These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 17388913

  • 1. Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.
    Milberg P, Hilker E, Ramtin S, Cakir Y, Stypmann J, Engelen MA, Mönnig G, Osada N, Breithardt G, Haverkamp W, Eckardt L.
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):647-54. PubMed ID: 17388913
    [Abstract] [Full Text] [Related]

  • 2. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P, Eckardt L, Bruns HJ, Biertz J, Ramtin S, Reinsch N, Fleischer D, Kirchhof P, Fabritz L, Breithardt G, Haverkamp W.
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [Abstract] [Full Text] [Related]

  • 3. Reduced repolarization reserve due to anthracycline therapy facilitates torsade de pointes induced by IKr blockers.
    Milberg P, Fleischer D, Stypmann J, Osada N, Mönnig G, Engelen MA, Bruch C, Breithardt G, Haverkamp W, Eckardt L.
    Basic Res Cardiol; 2007 Jan; 102(1):42-51. PubMed ID: 16817026
    [Abstract] [Full Text] [Related]

  • 4. Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3.
    Milberg P, Reinsch N, Osada N, Wasmer K, Mönnig G, Stypmann J, Breithardt G, Haverkamp W, Eckardt L.
    Basic Res Cardiol; 2005 Jul; 100(4):365-71. PubMed ID: 15944809
    [Abstract] [Full Text] [Related]

  • 5. Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3.
    Milberg P, Reinsch N, Wasmer K, Mönnig G, Stypmann J, Osada N, Breithardt G, Haverkamp W, Eckardt L.
    Cardiovasc Res; 2005 Feb 01; 65(2):397-404. PubMed ID: 15639478
    [Abstract] [Full Text] [Related]

  • 6. Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs.
    Thomsen MB, Verduyn SC, Stengl M, Beekman JD, de Pater G, van Opstal J, Volders PG, Vos MA.
    Circulation; 2004 Oct 19; 110(16):2453-9. PubMed ID: 15477402
    [Abstract] [Full Text] [Related]

  • 7. Experimental study on the mechanism of sex difference in the risk of torsade de pointes.
    Ruan YF, Liu N, Zhou Q, Li Y, Wang L.
    Chin Med J (Engl); 2004 Apr 19; 117(4):538-41. PubMed ID: 15109445
    [Abstract] [Full Text] [Related]

  • 8. A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure.
    Frommeyer G, Milberg P, Witte P, Stypmann J, Koopmann M, Lücke M, Osada N, Breithardt G, Fehr M, Eckardt L.
    Eur J Heart Fail; 2011 Oct 19; 13(10):1060-9. PubMed ID: 21873342
    [Abstract] [Full Text] [Related]

  • 9. Cisapride-induced transmural dispersion of repolarization and torsade de pointes in the canine left ventricular wedge preparation during epicardial stimulation.
    Di Diego JM, Belardinelli L, Antzelevitch C.
    Circulation; 2003 Aug 26; 108(8):1027-33. PubMed ID: 12912819
    [Abstract] [Full Text] [Related]

  • 10. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G, Borggrefe M, Eckardt L.
    J Cardiovasc Electrophysiol; 2007 Jun 26; 18(6):658-64. PubMed ID: 17521304
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Disturbances of cardiac wavelength and repolarization precede Torsade de Pointes and ventricular fibrillation in Langendorff perfused rabbit hearts.
    Hondeghem LM.
    Prog Biophys Mol Biol; 2016 May 26; 121(1):3-10. PubMed ID: 26980523
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.
    Lu HR, Vlaminckx E, Van de Water A, Rohrbacher J, Hermans A, Gallacher DJ.
    Eur J Pharmacol; 2006 Dec 28; 553(1-3):229-39. PubMed ID: 17054943
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block.
    Milberg P, Ramtin S, Mönnig G, Osada N, Wasmer K, Breithardt G, Haverkamp W, Eckardt L.
    J Cardiovasc Pharmacol; 2004 Sep 28; 44(3):278-86. PubMed ID: 15475823
    [Abstract] [Full Text] [Related]

  • 16. In vivo mechanisms precipitating torsades de pointes in a canine model of drug-induced long-QT1 syndrome.
    Gallacher DJ, Van de Water A, van der Linde H, Hermans AN, Lu HR, Towart R, Volders PG.
    Cardiovasc Res; 2007 Nov 01; 76(2):247-56. PubMed ID: 17669388
    [Abstract] [Full Text] [Related]

  • 17. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes.
    Antzelevitch C, Sun ZQ, Zhang ZQ, Yan GX.
    J Am Coll Cardiol; 1996 Dec 01; 28(7):1836-48. PubMed ID: 8962574
    [Abstract] [Full Text] [Related]

  • 18. Thorough QT/QTc not so thorough: removes torsadogenic predictors from the T-wave, incriminates safe drugs, and misses profibrillatory drugs.
    Hondeghem LM.
    J Cardiovasc Electrophysiol; 2006 Mar 01; 17(3):337-40. PubMed ID: 16643415
    [Abstract] [Full Text] [Related]

  • 19. Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia.
    Frommeyer G, von der Ahe H, Brücher B, Dechering DG, Lange PS, Reinke F, Wasmer K, Köbe J, Pott C, Mönnig G, Eckardt L.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct 01; 389(10):1073-80. PubMed ID: 27405774
    [Abstract] [Full Text] [Related]

  • 20. Transmural dispersion of repolarization as a preclinical marker of drug-induced proarrhythmia.
    Said TH, Wilson LD, Jeyaraj D, Fossa AA, Rosenbaum DS.
    J Cardiovasc Pharmacol; 2012 Aug 01; 60(2):165-71. PubMed ID: 22561361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.